Current status of newborn screening: decision-making about the conditions to include in screening programs.
Newborn screening is considered a highly successful public health program that has resulted in the reduction of mortality, mental retardation, and other serious disabilities in thousands of children since the introduction of screening for phenylketonuria (PKU) in the 1960s. Programs are based in state public health departments such that each state independently reaches decisions as to which conditions should be mandated for inclusion in programs, leading to considerable variability among the states as to what is being screened. New technologies and knowledge of the genetics of many conditions have greatly expanded the number of conditions with potential for inclusion in newborn screening.
Watson
Michael S
MS
American College of Medical Genetics, 9650 Rockville Pike, Bethesda, Maryland, USA. mwatson@acmg.net
D003659:Decision Making, Organizational; D005820:Genetic Testing; D006801:Humans; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000175:diagnosis* / Q000235:genetics; D015997:Neonatal Screening; D011237:Predictive Value of Tests; D012307:Risk Factors